Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04779918
NA

Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh

Sponsor: Tela Bio Inc

View on ClinicalTrials.gov

Summary

This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.

Official title: A Prospective Study Evaluating the Clinical Outcomes of Ventral or Inguinal Hernias Treated Robotically With OviTex® Reinforced Tissue Matrix

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2021-04-29

Completion Date

2027-12-30

Last Updated

2025-10-10

Healthy Volunteers

Yes

Interventions

DEVICE

OviTex Reinforced Tissue Matrix

All study subjects will receive OviTex. All OviTex Reinforced Tissue Matrices are intended for use as a surgical mesh to reinforce or repair soft tissue where weakness exists.

Locations (10)

University of South Alabama

Mobile, Alabama, United States

SurgOne

Denver, Colorado, United States

GenesisCare

Destin, Florida, United States

Surgical Healing Arts Center

Fort Myers, Florida, United States

St. Luke's Hospital

Overland Park, Kansas, United States

University of Louisville

Louisville, Kentucky, United States

Munson Healthcare

Traverse City, Michigan, United States

St. Francis Hospital

Roslyn, New York, United States

Mohawk Valley Health System

Utica, New York, United States

Houston Methodist

Houston, Texas, United States